Independent Franchise Partners files 13G/A on Solventum, 7.44%

Rhea-AI Filing Summary

Independent Franchise Partners, LLP filed an amended Schedule 13G 12,899,240 shares of Solventum Corporation common stock, representing 7.44% of the class as of 09/30/2025.

The filer reports 12,626,471 shares with sole voting power and 77,036 with shared voting power. It has 12,899,240 shares with sole dispositive power and 0 with shared dispositive power. The filing certifies the securities were acquired and are held in the ordinary course of business and not with the purpose or effect of changing or influencing control of the issuer.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

SOLVENTUM CORPORATION

(Name of Issuer)

Common Stock, Par Value $.01 Per Share

(Title of Class of Securities)

83444M101

(CUSIP Number)

09/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 83444M101

1

Names of Reporting Persons

Independent Franchise Partners, LLP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED KINGDOM

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 12,626,471.00
6	Shared Voting Power 77,036.00
7	Sole Dispositive Power 12,899,240.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

12,899,240.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.44 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: SOLVENTUM CORPORATION
(b)	Address of issuer's principal executive offices: 3M Center, Building 275-6W 2510 Conway Avenue East, Maplewood, Minnesota 55144
Item 2.
(a)	Name of person filing: Independent Franchise Partners, LLP
(b)	Address or principal business office or, if none, residence: Level 1, 10 Portman Square, London W1H 6AZ, United Kingdom
(c)	Citizenship: United Kingdom
(d)	Title of class of securities: Common Stock, Par Value $.01 Per Share
(e)	CUSIP No.: 83444M101
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 12,899,240
(b)	Percent of class: 7.44%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 12,626,471
	(ii) Shared power to vote or to direct the vote: 77,036
	(iii) Sole power to dispose or to direct the disposition of: 12,899,240
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Independent Franchise Partners, LLP

Signature:	Sandeep Ghela
Name/Title:	Sandeep Ghela | Chief Operating Officer
Date:	11/13/2025

FAQ

What did Independent Franchise Partners report about SOLV?

They reported beneficial ownership of 12,899,240 Solventum shares, equal to 7.44% of the class as of 09/30/2025.

What voting powers did IFP disclose for SOLV?

Sole voting power over 12,626,471 shares and shared voting power over 77,036 shares.

What dispositive powers did IFP disclose?

Sole dispositive power over 12,899,240 shares and shared dispositive power over 0 shares.

What is the filer type and citizenship of IFP?

It is classified as IA United Kingdom.

What certification did IFP include in the filing?

The securities were acquired and are held in the ordinary course of business and not to change or influence control.

What is the CUSIP for Solventum’s common stock?

The CUSIP is 83444M101.

What is the date of event for this ownership report?

The date of event is 09/30/2025.